LaPensee E - Search Results

1

Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element.

Kregel S, Bagamasbad P, He S, LaPensee E, Raji Y, Brogley M, Chinnaiyan A, Cieslik M, Robins DM. Kregel S, et al. Among authors: lapensee e. Nucleic Acids Res. 2020 May 21;48(9):4741-4755. doi: 10.1093/nar/gkaa178. Nucleic Acids Res. 2020. PMID: 32198885 Free PMC article.

2

Treatment-dependent androgen receptor mutations in prostate cancer exploit multiple mechanisms to evade therapy.

Steinkamp MP, O'Mahony OA, Brogley M, Rehman H, Lapensee EW, Dhanasekaran S, Hofer MD, Kuefer R, Chinnaiyan A, Rubin MA, Pienta KJ, Robins DM. Steinkamp MP, et al. Among authors: lapensee ew. Cancer Res. 2009 May 15;69(10):4434-42. doi: 10.1158/0008-5472.CAN-08-3605. Epub 2009 Apr 14. Cancer Res. 2009. PMID: 19366804 Free PMC article.

3

New directions in cancer and aging: State of the science and recommendations to improve the quality of evidence on the intersection of aging with cancer control.

Kobayashi LC, Westrick AC, Doshi A, Ellis KR, Jones CR, LaPensee E, Mondul AM, Mullins MA, Wallner LP. Kobayashi LC, et al. Among authors: lapensee e. Cancer. 2022 May 1;128(9):1730-1737. doi: 10.1002/cncr.34143. Epub 2022 Feb 23. Cancer. 2022. PMID: 35195912 Free PMC article. Review.

4

Prolactin confers resistance against cisplatin in breast cancer cells by activating glutathione-S-transferase.

LaPensee EW, Schwemberger SJ, LaPensee CR, Bahassi el M, Afton SE, Ben-Jonathan N. LaPensee EW, et al. Carcinogenesis. 2009 Aug;30(8):1298-304. doi: 10.1093/carcin/bgp120. Epub 2009 May 14. Carcinogenesis. 2009. PMID: 19443905 Free PMC article.

5

LS14 cells: a model for chemoresistance in liposarcoma.

LaPensee EW, Reddy SP, Hugo ER, Schwemberger SJ, Ben-Jonathan N. LaPensee EW, et al. Cancer Biol Ther. 2007 Apr;6(4):519-24. doi: 10.4161/cbt.6.4.3816. Cancer Biol Ther. 2007. PMID: 17426441

6

Mobilizing cross-disciplinary teams to advance translational research using design thinking methods.

LaPensee E, Doshi A, Salem B, Jazdzyk D, Steen K, Cantrell M, Somers E. LaPensee E, et al. J Clin Transl Sci. 2021 Jul 22;5(1):e184. doi: 10.1017/cts.2021.823. eCollection 2021. J Clin Transl Sci. 2021. PMID: 34849259 Free PMC article.

7

Bisphenol A at low nanomolar doses confers chemoresistance in estrogen receptor-alpha-positive and -negative breast cancer cells.

Lapensee EW, Tuttle TR, Fox SR, Ben-Jonathan N. Lapensee EW, et al. Environ Health Perspect. 2009 Feb;117(2):175-80. doi: 10.1289/ehp.11788. Epub 2008 Oct 8. Environ Health Perspect. 2009. PMID: 19270784 Free PMC article.

8

Bisphenol A and estradiol are equipotent in antagonizing cisplatin-induced cytotoxicity in breast cancer cells.

LaPensee EW, LaPensee CR, Fox S, Schwemberger S, Afton S, Ben-Jonathan N. LaPensee EW, et al. Cancer Lett. 2010 Apr 28;290(2):167-73. doi: 10.1016/j.canlet.2009.09.005. Epub 2009 Sep 30. Cancer Lett. 2010. PMID: 19796866 Free PMC article.

9

Novel roles of prolactin and estrogens in breast cancer: resistance to chemotherapy.

LaPensee EW, Ben-Jonathan N. LaPensee EW, et al. Endocr Relat Cancer. 2010 Feb 25;17(2):R91-107. doi: 10.1677/ERC-09-0253. Print 2010 Jun. Endocr Relat Cancer. 2010. PMID: 20071456 Review.

10

What can we learn from rodents about prolactin in humans?

Ben-Jonathan N, LaPensee CR, LaPensee EW. Ben-Jonathan N, et al. Endocr Rev. 2008 Feb;29(1):1-41. doi: 10.1210/er.2007-0017. Epub 2007 Dec 5. Endocr Rev. 2008. PMID: 18057139 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page